Status:
COMPLETED
Comparative Study of Low-Energy 1064nm Laser and DPL in Rosacea Treatment
Lead Sponsor:
Second Affiliated Hospital of Xi'an Jiaotong University
Conditions:
Rosacea
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Rosacea is a common skin disease characterized by transient flushing or persistent erythema and vasodilation symptoms on the face. In more severe cases, papules and pustules may appear in the central ...
Detailed Description
Rosacea is a common, chronic inflammatory skin disorder primarily affecting the face, characterized by episodic or persistent redness, visible blood vessels (vasodilation), and, in more severe cases, ...
Eligibility Criteria
Inclusion
- Those with a history of photosensitivity;
- Those who have combined with severe immunological diseases;
- Those with a tendency to form scars;
- Pregnant or lactating women;
- Alcoholics;
- Those with other facial disorders;
- Those with mental illness or mental disorders who cannot cooperate with treatment;
- During pregnancy or lactation;
- Those with serious internal medical diseases;
- Those with poor compliance or non-cooperation in mental disorders.
Exclusion
- Age range: 18 - 60 years old, gender not limited;
- Patients diagnosed with rosacea in bilateral facial lesion areas with basically symmetrical distribution based on dermoscopy and clinical manifestations;
- Patients with good cognitive function and normal mental state;
- Patients with good communication skills;
- Patients who voluntarily participate in this study and sign the informed consent form.
Key Trial Info
Start Date :
December 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06915636
Start Date
December 7 2024
End Date
March 1 2025
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Xi'an Jiaotong University
Xian, Shanxi, China, 710000